Page last updated: 2024-10-21

2-aminoethoxydiphenyl borate and Myasthenic Syndromes, Congenital

2-aminoethoxydiphenyl borate has been researched along with Myasthenic Syndromes, Congenital in 1 studies

2-aminoethoxydiphenyl borate: is a novel membrane-penetrable modulator and transient receptor potential channel blocker; structure in first source; do not confuse with 2-APB cpd
2-aminoethoxydiphenylborane : An organoboron compound that is diphenylborane in which the borane hydrogen is replaced by a 2-aminoethoxy group.

Myasthenic Syndromes, Congenital: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, H1
Bhattacharyya, BJ1
Lin, H1
Gomez, CM1

Other Studies

1 other study available for 2-aminoethoxydiphenyl borate and Myasthenic Syndromes, Congenital

ArticleYear
Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Oct-26, Volume: 31, Issue:43

    Topics: Action Potentials; Animals; Boron Compounds; Calcium; Calcium Signaling; Calpain; Carbachol; Caspase

2011